Sonara Health is on a mission to end the opioid epidemic and save lives! Nearly 100,000 people died of an opioid overdose last year, and approximately 12 million Americans misuse opioids. Sonara Health partners with federally regulated opioid treatment programs (OTPs) to help make treatment more accessible than illicit opioids. Sonara is a patent-pending, remote dosing system developed by physicians to establish trust and add assurance to the take-home methadone dosing process. Sonara provides OTPs with the confidence they need to approve more take-home doses responsibly, to improve quality of life for patients and expand treatment accessibility for those who live farther away from clinics. Notable investors in Mark Cuban and First Trust Capital.

Many patients at opioid treatment programs require daily visits, and most of these clinics are not set up to utilize remote treatment options. Sonara, our first product, is a telehealth platform designed to meet the highly specific needs of opioid treatment clinics and their patients. By increasing access to care for patients, financial incentives for clinics, and savings for payors, our platform will revolutionize the delivery of care for opioid use disorder.

Sonara is a medication adherence ecosystem that makes Methadone based treatment for Opioid Use Disorder more accessible and convenient for patients through a patented, tamper-aware medication monitoring system. 

We work with patients and their care teams to deliver a more sustainable treatment, improving patient retention and satisfaction in Opioid Treatment Programs. 

OpiSafe is an award-winning solution provider of platforms designed to manage the opioid response for prescribers, dispensers, public health agencies, and patients and their families. Their approach helps close the gap between the epidemic and the solutions that stakeholders need to respond.

OpiSafe is an award winning software company with three innovative software systems---OpiSafe, OpiRescue, and TreatmentGPS---that can be deployed by state agencies and health care systems/providers to assure safe opioid prescribing, prevent and respond to opioid overdoses, and increase access to treatment for persons with opioid use disorder. The systems connect to, and create interoperable flows of, data between several important sources: state Prescription Drug Monitoring Programs (PDMPs/PMPs), toxicology laboratories, Health Information Exchanges (HIEs), direct patient-reported data, and others, and merge them into decision support engines and interfaces that are integrated into clinical workflow (EHRs) for use by clinicians to improve care for patients, into dashboards for use by state agencies or health systems for population health initiatives, or into smartphone apps for use by patients and families.

In the months to come, Sonara Health was formed under Dr. Giles’ philosophy that facilitating humanized, compassionate and trustworthy interactions between OTP patients and providers will lead to greater outcomes and have a noticeable positive impact on the opioid epidemic.    

Assess a patient's holistic risk profile beyond the PDMP.